Product
cobicistat
Name
Tybost
INN Name
COBICISTAT
FDA Approved
Yes
1 clinical trial
1 organization
5 indications
1 document
Indication
Acute Myeloid LeukemiaIndication
Acute Lymphoblastic LeukemiaIndication
Mixed Lineage Acute LeukemiaIndication
Mixed Phenotype Acute LeukemiaIndication
Acute Leukemia of Ambiguous LineageClinical trial
A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients With Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) MutationStatus: Recruiting, Estimated PCD: 2024-12-01
Document
DailyMed Label: TybostOrganization
Gilead Sciences, Inc.